2003-2005: organization and structuring

2003 Creation of the Novacap group, Bain Capital is the majority shareholder of the group

2004 Start-up of a new sodium bicarbonate unit

2006-2011: organic development improvement

2006 Start-up of the calcium chloride unit in Pont-de-Claix (Performance Chemicals)

2008 Start-up of the second sodium bicarbonate unit (Mineral Specialties)

2010 Start-up of the Isopropanol unit in Roussillon (Performance Chemicals)

2011 Ardian acquires 96% of Novacap




2011-2017: growth acceleration with an international footprint

2011 Start-up of the third sodium bicarbonate unit (Mineral Specialties)

2011 Acquisition of Novacyl (Pharmaceutical & Cosmetics division)

2011 Start-up of a new ferric chloride production unit in Pont-de-Claix (France)

2012 Capacity expansion on Alpha Methyl Styrene (Performance Chemicals)

2013 Acquisition of a controlling stake (51%)  in Yangzi Pharmaceutical Chemical in China (Pharmaceutical & Cosmetics)

2014 Launch of homosalate(Pharmaceutical & Cosmetics), sodium silicates (Mineral Specialties)

Acquisition of a 51% controlling stake in Puyan (Pharmaceutical & Cosmetics)

2015 Acquisition of Uetikon (Pharmaceutical & Cosmetics) a German based APIs and Fine Chemicals manufacturer

2016 EURAZEO becomes the majority shareholder of the group alongside MERIEUX DEVELOPPEMNT, ARDIAN and the management team.



Since 2016 : Strengthening of technological and products offering for pharmaceutical, cosmetics and fine chemistry markets.


2017 Novacap acquires 96,5% of Puyuan (Pharmaceutical & Cosmetics)

2017 Novacap acquires 77,57% of Yangzi Pharmaceutical Chemical (Pharmaceutical & Cosmetics)

April 2017 Novacap announced a project of strategic combination with PCAS, specialising in the development and production of complex molecules for life sciences and innovative technologies, through a sale of blocks of shares followed by a tender offer.

April 2017 Startup of a new production unit of manufacture of DIPE (Diisopropyl Ether) on the Roussillon chemical platform.

May 2017 Novacap acquires ID bio, a manufacturer of botanical ingredients and H2B, a manufacturer of ingredients for in vitro diagnosis.

May 2017 Novacap acquires PCAS, specializes in the development and production of complex molecules for life sciences and innovative technologies.